The rational use of opioid analgesics for cancer pain with a critique of the WHO 3-step ladder /
| Other Authors: | |
|---|---|
| Format: | Electronic |
| Language: | English |
| Published: |
London :
Henry Stewart Talks,
2009
|
| Series: | Henry Stewart talks Biomedical & life sciences collection. Cancer pain management : advancing towards optimal symptom management.
|
| Subjects: |
Table of Contents:
- Contents: Who 3-step analgesic ladder for cancer pain
- Overview of WHO cancer pain programme
- Cancer pain: a global problem
- UK national cancer patient survey
- Cancer pain is still endemic in the developed world
- Pain characteristics
- Pain in advanced cancer
- 2007 EPIC survey
- What has been achieved?
- The problem
- The science of pain mechanisms and pain control
- Cancer pain is complex
- Cancer pain scenarios
- Aetiology of cancer pain
- Chronic pain is mediated by immune/inflammatory mechanisms
- The WHO resource allocation model
- Validation of WHO ladder
- What has impeded progress?
- What is an "adjuvant" in pain control?
- Current molecular neurotransmission targets for pain control
- The solution
- Several mechanism-based ways of treating cancer pain
- Pyramid of modern approaches to cancer pain
- Do anti-cancer treatments reduce pain?
- How do opioids reduce pain and are they all the same?